Koers Gujarat Themis Biosyn Ltd Bombay S.E.
Aandelen
GTHM
INE942C01029
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- | - |
|
Omzet 2022 | 1,15 mld. 13,76 mln. 0 12,87 mln. | Omzet 2023 | 1,49 mld. 17,85 mln. 0 16,7 mln. | Marktkapitalisatie | 9,97 mld. 119 mln. 0 112 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 436 mln. 5,22 mln. - 4,89 mln. | Nettowinst (verlies) 2023 | 580 mln. 6,95 mln. - 6,5 mln. | EV/omzet 2022 | 4,97 x |
Nettoliquiditeiten 2022 | 209 mln. 2,5 mln. 0 2,34 mln. | Nettoliquiditeiten 2023 | 84,84 mln. 1,02 mln. 0 951K | EV/omzet 2023 | 6,64 x |
K/w-verhouding 2022 |
13,6
x | K/w-verhouding 2023 |
17,2
x | Werknemers | - |
Dividendrendement 2022 |
1,47% | Dividendrendement 2023 |
0,79% | Vrij verhandelbaar | 27,98% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 07-08-14 | |
Director of Finance/CFO | - | - | |
Rahul Soni
CMP | Compliance Officer | - | 12-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 67 | 31-03-06 | |
Director/Board Member | 49 | 25-10-08 | |
Chairman | 75 | 25-05-92 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,05% | 43,67 mld. | |
+26,21% | 22,79 mld. | |
+20,73% | 15,45 mld. | |
+18,43% | 14,29 mld. | |
+53,47% | 12,83 mld. | |
-0,05% | 6,79 mld. | |
-11,88% | 6,52 mld. | |
+12,62% | 5,59 mld. | |
-8,87% | 5,73 mld. |
- Beurs
- Aandelen
- Koers GUJTHEM6
- Koers GTHM